SEASONAL ALLERGIC RHINITIS
Clinical trials for SEASONAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new SEASONAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for SEASONAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy pill could offer relief from sneezing and stuffy nose
Symptom relief Not yet recruitingThis study tests an experimental antihistamine called rupatifen fumarate for people with seasonal allergic rhinitis (hay fever). About 550 adults aged 18 to 65 with at least a 2-year history of seasonal allergies will take either the new drug, an existing antihistamine, or a plac…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New injection could tame seasonal allergy symptoms for those failed by standard treatments
Symptom relief Not yet recruitingThis Phase 3 trial tests an investigational injection called SHR-1819 in adults aged 18 to 75 with seasonal allergic rhinitis (hay fever) who haven't gotten enough relief from standard treatments like nasal sprays or antihistamines. The study compares the drug to a placebo to see…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
New shot for teen hay fever? early trial underway
Symptom relief Not yet recruitingThis phase 2 trial tests the safety of stapokibart injection in 15 teenagers aged 12-17 with seasonal allergic rhinitis (hay fever). Participants receive the drug alongside their usual allergy treatments. The study focuses on side effects and how the body processes the drug, not …
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New allergy drug AK139 aims to stop sneezing and stuffy noses
Symptom relief Not yet recruitingThis study tests a new medicine called AK139 for people with moderate to severe seasonal allergic rhinitis (hay fever). About 111 adults aged 18-65 with at least a 2-year history of seasonal allergies will receive either AK139 or a placebo. The main goal is to see if AK139 reduce…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Akeso • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC